{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:26Z","timestamp":1793962406707,"version":"4.8.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41584-020-00533-7","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T10:07:12Z","timestamp":1605694032000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":724,"title":["Mechanisms and therapeutic implications of cellular senescence in osteoarthritis"],"prefix":"10.1038","volume":"17","author":[{"given":"Philip R.","family":"Coryell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian O.","family":"Diekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2832-6144","authenticated-orcid":false,"given":"Richard F.","family":"Loeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"533_CR1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"RF Loeser","year":"2012","unstructured":"Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64, 1697\u20131707 (2012).","journal-title":"Arthritis Rheum."},{"key":"533_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser, R. F., Collins, J. A. & Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412\u2013420 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"533_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2014.01.004","volume":"28","author":"VL Johnson","year":"2014","unstructured":"Johnson, V. L. & Hunter, D. J. The epidemiology of osteoarthritis. Best Pract. Res. Clin. Rheumatol. 28, 5\u201315 (2014).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"533_CR4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/acr.22721","volume":"68","author":"MG Cisternas","year":"2016","unstructured":"Cisternas, M. G. et al. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 68, 574\u2013580 (2016).","journal-title":"Arthritis Care Res."},{"key":"533_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21562","volume":"54","author":"JM Hootman","year":"2006","unstructured":"Hootman, J. M. & Helmick, C. G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 54, 226\u2013229 (2006).","journal-title":"Arthritis Rheum."},{"key":"533_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/acr.22412","volume":"67","author":"E Losina","year":"2015","unstructured":"Losina, E. et al. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res. 67, 203\u2013215 (2015).","journal-title":"Arthritis Care Res."},{"key":"533_CR7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"533_CR8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2017.05.015","volume":"169","author":"S He","year":"2017","unstructured":"He, S. & Sharpless, N. E. Senescence in health and disease. Cell 169, 1000\u20131011 (2017).","journal-title":"Cell"},{"key":"533_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/acel.12562","volume":"16","author":"K McCulloch","year":"2017","unstructured":"McCulloch, K., Litherland, G. J. & Rai, T. S. Cellular senescence in osteoarthritis pathology. Aging Cell 16, 210\u2013218 (2017).","journal-title":"Aging Cell"},{"key":"533_CR10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI95147","volume":"128","author":"OH Jeon","year":"2018","unstructured":"Jeon, O. H., David, N., Campisi, J. & Elisseeff, J. H. Senescent cells and osteoarthritis: a painful connection. J. Clin. Invest. 128, 1229\u20131237 (2018).","journal-title":"J. Clin. Invest."},{"key":"533_CR11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16, 718\u2013735 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"533_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585\u2013621 (1961).","journal-title":"Exp. Cell Res."},{"key":"533_CR13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1474-9726.2012.00870.x","volume":"11","author":"D Jurk","year":"2012","unstructured":"Jurk, D. et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996\u20131004 (2012).","journal-title":"Aging Cell"},{"key":"533_CR14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/jbmr.2892","volume":"31","author":"JN Farr","year":"2016","unstructured":"Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920\u20131929 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"533_CR15","doi-asserted-by":"crossref","first-page":"27661","DOI":"10.18632\/oncotarget.15742","volume":"8","author":"DJ Baker","year":"2017","unstructured":"Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J. & Hildesheim, J. Oncogenic senescence: a multi-functional perspective. Oncotarget 8, 27661\u201327672 (2017).","journal-title":"Oncotarget"},{"key":"533_CR16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbrc.2014.08.123","volume":"452","author":"M Sasaki","year":"2014","unstructured":"Sasaki, M., Kajiya, H., Ozeki, S., Okabe, K. & Ikebe, T. Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a.). Biochem. Biophys. Res. Commun. 452, 622\u2013628 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"533_CR17","doi-asserted-by":"crossref","first-page":"111149","DOI":"10.1016\/j.mad.2019.111149","volume":"183","author":"R Sanokawa-Akakura","year":"2019","unstructured":"Sanokawa-Akakura, R., Akakura, S., Ostrakhovitch, E. A. & Tabibzadeh, S. Replicative senescence is distinguishable from DNA damage-induced senescence by increased methylation of promoter of rDNA and reduced expression of rRNA. Mech. Ageing Dev. 183, 111149 (2019).","journal-title":"Mech. Ageing Dev."},{"key":"533_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"JM van Deursen","year":"2014","unstructured":"van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439\u2013446 (2014).","journal-title":"Nature"},{"key":"533_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118 (2010).","journal-title":"Annu. Rev. Pathol."},{"key":"533_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1289\/ehp.919359","volume":"93","author":"R Sager","year":"1991","unstructured":"Sager, R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93, 59\u201362 (1991).","journal-title":"Environ. Health Perspect."},{"key":"533_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"J Campisi","year":"2013","unstructured":"Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685\u2013705 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"533_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gde.2010.10.005","volume":"21","author":"J Campisi","year":"2011","unstructured":"Campisi, J. Cellular senescence: putting the paradoxes in perspective. Curr. Opin. Genet. Dev. 21, 107\u2013112 (2011).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"533_CR23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","volume":"155","author":"M Storer","year":"2013","unstructured":"Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119\u20131130 (2013).","journal-title":"Cell"},{"key":"533_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"533_CR25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","volume":"17","author":"N Herranz","year":"2015","unstructured":"Herranz, N. et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205\u20131217 (2015).","journal-title":"Nat. Cell Biol."},{"key":"533_CR26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ncb3195","volume":"17","author":"RM Laberge","year":"2015","unstructured":"Laberge, R. M. et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17, 1049\u20131061 (2015).","journal-title":"Nat. Cell Biol."},{"key":"533_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J. & Kirkland, J. L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123, 966\u2013972 (2013).","journal-title":"J. Clin. Invest."},{"key":"533_CR28","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/art.27528","volume":"62","author":"MK Lotz","year":"2010","unstructured":"Lotz, M. K. et al. Cartilage cell clusters. Arthritis Rheum. 62, 2206\u20132218 (2010).","journal-title":"Arthritis Rheum."},{"key":"533_CR29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.tibs.2019.06.011","volume":"44","author":"M Ogrodnik","year":"2019","unstructured":"Ogrodnik, M., Salmonowicz, H., Jurk, D. & Passos, J. F. Expansion and cell-cycle arrest: common denominators of cellular senescence. Trends Biochem. Sci. 44, 996\u20131008 (2019).","journal-title":"Trends Biochem. Sci."},{"key":"533_CR30","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12771","volume":"17","author":"BO Diekman","year":"2018","unstructured":"Diekman, B. O. et al. Expression of p16INK 4a is a biomarker of chondrocyte aging but does not cause osteoarthritis. Aging Cell 17, e12771 (2018).","journal-title":"Aging Cell"},{"key":"533_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12979-019-0169-4","volume":"16","author":"MJ Del Rey","year":"2019","unstructured":"Del Rey, M. J. et al. Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype. Immun. Ageing 16, 29 (2019).","journal-title":"Immun. Ageing"},{"key":"533_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775\u2013781 (2017).","journal-title":"Nat. Med."},{"key":"533_CR33","first-page":"479","volume":"41","author":"JA Martin","year":"2004","unstructured":"Martin, J. A., Brown, T., Heiner, A. & Buckwalter, J. A. Post-traumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology 41, 479\u2013491 (2004).","journal-title":"Biorheology"},{"key":"533_CR34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2337\/db15-0291","volume":"65","author":"MJ Schafer","year":"2016","unstructured":"Schafer, M. J. et al. Exercise prevents diet-induced cellular senescence in adipose tissue. Diabetes 65, 1606\u20131615 (2016).","journal-title":"Diabetes"},{"key":"533_CR35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132 (2020).","journal-title":"Nature"},{"key":"533_CR36","first-page":"105","volume":"19","author":"W Schwab","year":"2004","unstructured":"Schwab, W. et al. Interleukin-1\u03b2-induced expression of the urokinase-type plasminogen activator receptor and its co-localization with MMPs in human articular chondrocytes. Histol. Histopathol. 19, 105\u2013112 (2004).","journal-title":"Histol. Histopathol."},{"key":"533_CR37","first-page":"780","volume":"72","author":"M Xu","year":"2017","unstructured":"Xu, M. et al. Transplanted senescent cells induce an osteoarthritis-like condition in mice. J. Gerontol. A Biol. Sci. Med. Sci. 72, 780\u2013785 (2017).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"533_CR38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","volume":"17","author":"RF Loeser","year":"2009","unstructured":"Loeser, R. F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr. Cartil. 17, 971\u2013979 (2009).","journal-title":"Osteoarthr. Cartil."},{"key":"533_CR39","volume":"7","author":"MJ Pearson","year":"2017","unstructured":"Pearson, M. J. et al. IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity. Sci. Rep. 7, 3451 (2017).","journal-title":"Sci. Rep."},{"key":"533_CR40","volume":"2","author":"H Kojima","year":"2013","unstructured":"Kojima, H., Inoue, T., Kunimoto, H. & Nakajima, K. IL-6-STAT3 signaling and premature senescence. JAKSTAT 2, e25763 (2013).","journal-title":"JAKSTAT"},{"key":"533_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1474-9726.2012.00795.x","volume":"11","author":"G Nelson","year":"2012","unstructured":"Nelson, G. et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell 11, 345\u2013349 (2012).","journal-title":"Aging Cell"},{"key":"533_CR42","volume":"4","author":"OH Jeon","year":"2019","unstructured":"Jeon, O. H. et al. Senescence cell-associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers. JCI Insight 4, e125019 (2019).","journal-title":"JCI Insight"},{"key":"533_CR43","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J. & Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-\u03b2gal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798\u20131806 (2009).","journal-title":"Nat. Protoc."},{"key":"533_CR44","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363\u20139367 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"533_CR45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","volume":"5","author":"BY Lee","year":"2006","unstructured":"Lee, B. Y. et al. Senescence-associated \u03b2-galactosidase is lysosomal \u03b2-galactosidase. Aging Cell 5, 187\u2013195 (2006).","journal-title":"Aging Cell"},{"key":"533_CR46","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1080\/15384101.2016.1234547","volume":"15","author":"A Baisantry","year":"2016","unstructured":"Baisantry, A. et al. The impact of autophagy on the development of senescence in primary tubular epithelial cells. Cell Cycle 15, 2973\u20132979 (2016).","journal-title":"Cell Cycle"},{"key":"533_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088071","volume":"9","author":"B Berkenkamp","year":"2014","unstructured":"Berkenkamp, B. et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE 9, e88071 (2014).","journal-title":"PLoS ONE"},{"key":"533_CR48","doi-asserted-by":"crossref","first-page":"81099","DOI":"10.18632\/oncotarget.12752","volume":"7","author":"M Piechota","year":"2016","unstructured":"Piechota, M. et al. Is senescence-associated \u03b2-galactosidase a marker of neuronal senescence? Oncotarget 7, 81099\u201381109 (2016).","journal-title":"Oncotarget"},{"key":"533_CR49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/03008207.2016.1240790","volume":"58","author":"H Jeon","year":"2017","unstructured":"Jeon, H. & Im, G. I. Autophagy in osteoarthritis. Connect. Tissue Res. 58, 497\u2013508 (2017).","journal-title":"Connect. Tissue Res."},{"key":"533_CR50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.27305","volume":"62","author":"B Carames","year":"2010","unstructured":"Carames, B., Taniguchi, N., Otsuki, S., Blanco, F. J. & Lotz, M. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 62, 791\u2013801 (2010).","journal-title":"Arthritis Rheum."},{"key":"533_CR51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/annrheumdis-2011-200557","volume":"71","author":"B Carames","year":"2012","unstructured":"Carames, B. et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann. Rheum. Dis. 71, 575\u2013581 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR52","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13171","volume":"19","author":"PR Coryell","year":"2020","unstructured":"Coryell, P. R. et al. Autophagy regulates the localization and degradation of p16ink4a. Aging Cell 19, e13171 (2020).","journal-title":"Aging Cell"},{"key":"533_CR53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280\u2013293 (2010).","journal-title":"Mol. Cell"},{"key":"533_CR54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1101\/gad.934301","volume":"15","author":"E Schipani","year":"2001","unstructured":"Schipani, E. et al. Hypoxia in cartilage: HIF-1\u03b1 is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865\u20132876 (2001).","journal-title":"Genes Dev."},{"key":"533_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/excr.1997.3824","volume":"237","author":"M Serrano","year":"1997","unstructured":"Serrano, M. The tumor suppressor protein p16ink4a. Exp. Cell Res. 237, 7\u201313 (1997).","journal-title":"Exp. Cell Res."},{"key":"533_CR56","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein, A. M. et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16ink4 mutations. N. Engl. J. Med. 333, 970\u2013974 (1995).","journal-title":"N. Engl. J. Med."},{"key":"533_CR57","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jnci\/89.10.676","volume":"89","author":"AM Goldstein","year":"1997","unstructured":"Goldstein, A. M. & Tucker, M. A. Screening for CDKN2A mutations in hereditary melanoma. J. Natl Cancer Inst. 89, 676\u2013678 (1997).","journal-title":"J. Natl Cancer Inst."},{"key":"533_CR58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI22475","volume":"114","author":"J Krishnamurthy","year":"2004","unstructured":"Krishnamurthy, J. et al. Ink4a\/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299\u20131307 (2004).","journal-title":"J. Clin. Invest."},{"key":"533_CR59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"533_CR60","doi-asserted-by":"crossref","first-page":"36396","DOI":"10.1074\/jbc.M111.257071","volume":"286","author":"JP Coppe","year":"2011","unstructured":"Coppe, J. P. et al. Tumor suppressor and aging biomarker p16(Ink4a) induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 286, 36396\u201336403 (2011).","journal-title":"J. Biol. Chem."},{"key":"533_CR61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature03260","volume":"433","author":"IM Conboy","year":"2005","unstructured":"Conboy, I. M. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760\u2013764 (2005).","journal-title":"Nature"},{"key":"533_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13363","volume":"7","author":"J Rebo","year":"2016","unstructured":"Rebo, J. et al. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat. Commun. 7, 13363 (2016).","journal-title":"Nat. Commun."},{"key":"533_CR63","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.41230","volume":"72","author":"L Li","year":"2020","unstructured":"Li, L. et al. Positive effects of a young systemic environment and high growth differentiation factor 11 levels on chondrocyte proliferation and cartilage matrix synthesis in old mice. Arthritis Rheumatol. 72, 1123\u20131133 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"533_CR64","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"533_CR65","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-07-6538","volume":"68","author":"BD Lehmann","year":"2008","unstructured":"Lehmann, B. D. et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68, 7864\u20137871 (2008).","journal-title":"Cancer Res."},{"key":"533_CR66","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1096\/fj.14-254565","volume":"28","author":"T Effenberger","year":"2014","unstructured":"Effenberger, T. et al. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding. FASEB J. 28, 4847\u20134856 (2014).","journal-title":"FASEB J."},{"key":"533_CR67","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/nar\/gkt1096","volume":"42","author":"MG Overhoff","year":"2014","unstructured":"Overhoff, M. G. et al. Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic Acids Res. 42, 1606\u20131618 (2014).","journal-title":"Nucleic Acids Res."},{"key":"533_CR68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01386-z","volume":"7","author":"E Eitan","year":"2017","unstructured":"Eitan, E. et al. Age-related changes in plasma extracellular vesicle characteristics and internalization by leukocytes. Sci. Rep. 7, 1342 (2017).","journal-title":"Sci. Rep."},{"key":"533_CR69","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/art.24745","volume":"60","author":"S Miyaki","year":"2009","unstructured":"Miyaki, S. et al. Microrna-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 60, 2723\u20132730 (2009).","journal-title":"Arthritis Rheum."},{"key":"533_CR70","first-page":"205378","volume":"2011","author":"A Feliciano","year":"2011","unstructured":"Feliciano, A., Sanchez-Sendra, B., Kondoh, H. & Lleonart, M. E. Micrornas regulate key effector pathways of senescence. J. Aging Res. 2011, 205378 (2011).","journal-title":"J. Aging Res."},{"key":"533_CR71","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.3390\/ijms140917897","volume":"14","author":"K Venkataraman","year":"2013","unstructured":"Venkataraman, K., Khurana, S. & Tai, T. C. Oxidative stress in aging\u2013matters of the heart and mind. Int. J. Mol. Sci. 14, 17897\u201317925 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"533_CR72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.redox.2015.03.004","volume":"5","author":"DP Jones","year":"2015","unstructured":"Jones, D. P. Redox theory of aging. Redox Biol. 5, 71\u201379 (2015).","journal-title":"Redox Biol."},{"key":"533_CR73","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/annrheumdis-2014-206295","volume":"75","author":"W Hui","year":"2016","unstructured":"Hui, W. et al. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann. Rheum. Dis. 75, 449\u2013458 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR74","first-page":"44","volume":"128","author":"RF Loeser","year":"2017","unstructured":"Loeser, R. F. The role of aging in the development of osteoarthritis. Trans. Am. Clin. Climatol. Assoc. 128, 44\u201354 (2017).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"533_CR75","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/art.39099","volume":"67","author":"HM Ismail","year":"2015","unstructured":"Ismail, H. M. et al. Interleukin-1 acts via the JNK-2 signaling pathway to induce aggrecan degradation by human chondrocytes. Arthritis Rheumatol. 67, 1826\u20131836 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"533_CR76","doi-asserted-by":"crossref","first-page":"16376","DOI":"10.1074\/jbc.RA118.004613","volume":"293","author":"KJ Nelson","year":"2018","unstructured":"Nelson, K. J. et al. H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes. J. Biol. Chem. 293, 16376\u201316389 (2018).","journal-title":"J. Biol. Chem."},{"key":"533_CR77","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/art.41312","volume":"72","author":"RF Loeser","year":"2020","unstructured":"Loeser, R. F. et al. Deletion of c-Jun N-terminal kinase enhances senescence in joint tissues and increases the severity of age-related osteoarthritis in mice. Arthritis Rheumatol. 72, 1679\u20131688 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"533_CR78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/msb.2010.5","volume":"6","author":"JF Passos","year":"2010","unstructured":"Passos, J. F. et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6, 347 (2010).","journal-title":"Mol. Syst. Biol."},{"key":"533_CR79","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/art.10496","volume":"46","author":"RF Loeser","year":"2002","unstructured":"Loeser, R. F., Carlson, C. S., Del Carlo, M. & Cole, A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1\u03b2 and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum. 46, 2349\u20132357 (2002).","journal-title":"Arthritis Rheum."},{"key":"533_CR80","doi-asserted-by":"crossref","first-page":"R380","DOI":"10.1186\/ar1499","volume":"7","author":"K Yudoh","year":"2005","unstructured":"Yudoh, K. et al. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res. Ther. 7, R380\u2013R391 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"533_CR81","doi-asserted-by":"crossref","first-page":"38966","DOI":"10.1074\/jbc.M307146200","volume":"278","author":"G Blander","year":"2003","unstructured":"Blander, G., de Oliveira, R. M., Conboy, C. M., Haigis, M. & Guarente, L. Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J. Biol. Chem. 278, 38966\u201338969 (2003).","journal-title":"J. Biol. Chem."},{"key":"533_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.redox.2016.10.014","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. A new role for oxidative stress in aging: the accelerated aging phenotype in Sod1\u2212\/\u2212 mice is correlated to increased cellular senescence. Redox Biol. 11, 30\u201337 (2017).","journal-title":"Redox Biol."},{"key":"533_CR83","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1002\/art.21387","volume":"52","author":"E Regan","year":"2005","unstructured":"Regan, E. et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum. 52, 3479\u20133491 (2005).","journal-title":"Arthritis Rheum."},{"key":"533_CR84","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/ard.2009.119966","volume":"69","author":"JL Scott","year":"2010","unstructured":"Scott, J. L. et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis. 69, 1502\u20131510 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR85","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2017.7167","volume":"28","author":"SG Rhee","year":"2018","unstructured":"Rhee, S. G., Woo, H. A. & Kang, D. The role of peroxiredoxins in the transduction of H2O2 signals. Antioxid. Redox Signal. 28, 537\u2013557 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"533_CR86","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1074\/jbc.M115.693523","volume":"291","author":"JA Collins","year":"2016","unstructured":"Collins, J. A. et al. Oxidative stress promotes peroxiredoxin hyperoxidation and attenuates pro-survival signaling in aging chondrocytes. J. Biol. Chem. 291, 6641\u20136654 (2016).","journal-title":"J. Biol. Chem."},{"key":"533_CR87","first-page":"821","volume":"42","author":"C Kang","year":"2019","unstructured":"Kang, C. Senolytics and senostatics: a two-pronged approach to target cellular senescence for delaying aging and age-related diseases. Mol. Cell 42, 821\u2013827 (2019).","journal-title":"Mol. Cell"},{"key":"533_CR88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"533_CR89","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644\u2013658 (2015).","journal-title":"Aging Cell"},{"key":"533_CR90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78\u201383 (2016).","journal-title":"Nat. Med."},{"key":"533_CR91","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1096\/fj.201900815RR","volume":"33","author":"GA Sessions","year":"2019","unstructured":"Sessions, G. A. et al. Controlled induction and targeted elimination of p16(INK4a)-expressing chondrocytes in cartilage explant culture. FASEB J. 33, 12364\u201312373 (2019).","journal-title":"FASEB J."},{"key":"533_CR92","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456 (2019).","journal-title":"EBioMedicine"},{"key":"533_CR93","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","volume":"40","author":"JN Justice","year":"2019","unstructured":"Justice, J. N. et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554\u2013563 (2019).","journal-title":"EBioMedicine"},{"key":"533_CR94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00063030-200822010-00007","volume":"22","author":"SJ Keam","year":"2008","unstructured":"Keam, S. J. Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. BioDrugs 22, 59\u201369 (2008).","journal-title":"BioDrugs"},{"key":"533_CR95","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246\u20131256 (2018).","journal-title":"Nat. Med."},{"key":"533_CR96","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079 (2017).","journal-title":"Nat. Med."},{"key":"533_CR97","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03513016 (2020)."},{"key":"533_CR98","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04229225 (2020)."},{"key":"533_CR99","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04349956 (2020)."},{"key":"533_CR100","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/annrheumdis-2020-217072","volume":"79","author":"G Batshon","year":"2020","unstructured":"Batshon, G. et al. Serum NT\/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence. Ann. Rheum. Dis. 79, 1370\u20131380 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR101","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/annrheumdis-2012-202620","volume":"73","author":"T Matsuzaki","year":"2014","unstructured":"Matsuzaki, T. et al. Disruption of SIRT1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann. Rheum. Dis. 73, 1397\u20131404 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR102","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ebiom.2019.06.049","volume":"45","author":"U Nogueira-Recalde","year":"2019","unstructured":"Nogueira-Recalde, U. et al. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine 45, 588\u2013605 (2019).","journal-title":"EBioMedicine"},{"key":"533_CR103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh, M. J. et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36, 18\u201328 (2018).","journal-title":"EBioMedicine"},{"key":"533_CR104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2017.02.009","volume":"45","author":"W Zheng","year":"2017","unstructured":"Zheng, W. et al. Fisetin inhibits IL-1\u03b2-induced inflammatory response in human osteoarthritis chondrocytes through activating sirt1 and attenuates the progression of osteoarthritis in mice. Int. Immunopharmacol. 45, 135\u2013147 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"533_CR105","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04210986 (2020)."},{"key":"533_CR106","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1172\/JCI83676","volume":"126","author":"M Zhang","year":"2016","unstructured":"Zhang, M. et al. Induced superficial chondrocyte death reduces catabolic cartilage damage in murine posttraumatic osteoarthritis. J. Clin. Invest. 126, 2893\u20132902 (2016).","journal-title":"J. Clin. Invest."},{"key":"533_CR107","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1387\/ijdb.180081my","volume":"62","author":"MH Yun","year":"2018","unstructured":"Yun, M. H. Cellular senescence in tissue repair: every cloud has a silver lining. Int. J. Dev. Biol. 62, 591\u2013604 (2018).","journal-title":"Int. J. Dev. Biol."},{"key":"533_CR108","volume":"4","author":"MH Yun","year":"2015","unstructured":"Yun, M. H., Davaapil, H. & Brockes, J. P. Recurrent turnover of senescent cells during regeneration of a complex structure. eLife 4, e05505 (2015).","journal-title":"eLife"},{"key":"533_CR109","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1073\/pnas.1300290110","volume":"110","author":"JW Godwin","year":"2013","unstructured":"Godwin, J. W., Pinto, A. R. & Rosenthal, N. A. Macrophages are required for adult salamander limb regeneration. Proc. Natl Acad. Sci. USA 110, 9415\u20139420 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"533_CR110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722\u2013733 (2014).","journal-title":"Dev. Cell"},{"key":"533_CR111","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI45785","volume":"122","author":"JS Tilstra","year":"2012","unstructured":"Tilstra, J. S. et al. NF-\u03baB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601\u20132612 (2012).","journal-title":"J. Clin. Invest."},{"key":"533_CR112","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","volume":"112","author":"M Xu","year":"2015","unstructured":"Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl Acad. Sci. USA 112, E6301\u2013E6310 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"533_CR113","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nchembio.2342","volume":"13","author":"HT Kang","year":"2017","unstructured":"Kang, H. T. et al. Chemical screening identifies ATM as a target for alleviating senescence. Nat. Chem. Biol. 13, 616\u2013623 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"533_CR114","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1172\/JCI84164","volume":"126","author":"SJ Lee","year":"2016","unstructured":"Lee, S. J. et al. Interruption of progerin-lamin A\/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype. J. Clin. Invest. 126, 3879\u20133893 (2016).","journal-title":"J. Clin. Invest."},{"key":"533_CR115","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1096\/fj.15-278846","volume":"30","author":"YU Bae","year":"2016","unstructured":"Bae, Y. U., Choi, J. H., Nagy, A., Sung, H. K. & Kim, J. R. Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF\/FGF pathway. FASEB J. 30, 1276\u20131286 (2016).","journal-title":"FASEB J."},{"key":"533_CR116","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/gerona\/gly208","volume":"74","author":"YU Bae","year":"2019","unstructured":"Bae, Y. U. et al. Embryonic stem cell-derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF-\u03b2 receptor 2 pathway. J. Gerontol. A Biol. Sci. Med. Sci. 74, 1359\u20131367 (2019).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"533_CR117","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5483\/BMBRep.2019.52.1.293","volume":"52","author":"EC Kim","year":"2019","unstructured":"Kim, E. C. & Kim, J. R. Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep. 52, 47\u201355 (2019).","journal-title":"BMB Rep."},{"key":"533_CR118","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.147.11.3915","volume":"147","author":"J Stadler","year":"1991","unstructured":"Stadler, J. et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147, 3915\u20133920 (1991).","journal-title":"J. Immunol."},{"key":"533_CR119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0049-0172(91)90024-T","volume":"20","author":"JP Pelletier","year":"1991","unstructured":"Pelletier, J. P., Roughley, P. J., DiBattista, J. A., McCollum, R. & Martel-Pelletier, J. Are cytokines involved in osteoarthritic pathophysiology? Semin. Arthritis Rheum. 20, 12\u201325 (1991).","journal-title":"Semin. Arthritis Rheum."},{"key":"533_CR120","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","volume":"71","author":"RM Fleischmann","year":"2019","unstructured":"Fleischmann, R. M. et al. A phase II trial of lutikizumab, an anti-interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis. Arthritis Rheumatol. 71, 1056\u20131069 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"533_CR121","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","volume":"77","author":"M Kloppenburg","year":"2018","unstructured":"Kloppenburg, M. et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 77, 1757\u20131764 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"533_CR122","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker, M. et al. Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: Exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 173, 509\u2013515 (2020).","journal-title":"Ann. Intern. Med."},{"key":"533_CR123","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen, J. S. et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371, 987\u2013997 (2008).","journal-title":"Lancet"},{"key":"533_CR124","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02477059 (2019)."},{"key":"533_CR125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.joca.2004.09.011","volume":"13","author":"AS de Hooge","year":"2005","unstructured":"de Hooge, A. S. et al. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthr. Cartil. 13, 66\u201373 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"533_CR126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti, M. P. & Brinckerhoff, C. E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4, 157\u2013164 (2002).","journal-title":"Arthritis Res."},{"key":"533_CR127","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1827.2010.02547.x","volume":"60","author":"T Shiomi","year":"2010","unstructured":"Shiomi, T., Lemaitre, V., D\u2019Armiento, J. & Okada, Y. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol. Int. 60, 477\u2013496 (2010).","journal-title":"Pathol. Int."},{"key":"533_CR128","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1002\/art.21300","volume":"52","author":"HI Roach","year":"2005","unstructured":"Roach, H. I. et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52, 3110\u20133124 (2005).","journal-title":"Arthritis Rheum."},{"key":"533_CR129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI10564","volume":"107","author":"LA Neuhold","year":"2001","unstructured":"Neuhold, L. A. et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107, 35\u201344 (2001).","journal-title":"J. Clin. Invest."},{"key":"533_CR130","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar4133","volume":"15","author":"M Wang","year":"2013","unstructured":"Wang, M. et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15, R5 (2013).","journal-title":"Arthritis Res. Ther."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-00533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-00533-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-00533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:25:41Z","timestamp":1697113541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-00533-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-00533-7","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"16 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.F.L. has consulted for Unity Biotechnology (<$1,000). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}